E2108: Early Local Therapy for Metastatic Breast Cancer
E2108: A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
Must have biopsy-proven breast cancer with at least one distant lesion that can be biopsied.
Cannot have CNS (central nervous system) metastasis.
Patients must be judged to be candidated for complete resection of their primary tumor, with no tumor left behind ast the site.
This trial has numerous additional inclusion/exlusion criteria. All of the criteria must be met before a patient can be eligible to participate.